BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21150074)

  • 21. 'Hyperacute' Guillain-Barré syndrome.
    Steiner I; Wirguin I; Blumen SC; Dano M; Raphaeli G; Schwartz I; Korn-Lubetzki I
    Eur Neurol; 2008; 59(1-2):88-90. PubMed ID: 17934279
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".
    Buenz EJ
    J Clin Neurosci; 2009 Aug; 16(8):1110; author reply 1111. PubMed ID: 19467870
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased levels of Monocyte Chemoattractant Protein-1 in cerebrospinal fluid with gamma globulin induced meningitis.
    Asano T; Koizumi S; Mishina-Ikegami K; Hatori T; Miyasho T; Fujino O
    Acta Paediatr; 2010 Feb; 99(2):164-5. PubMed ID: 19832741
    [No Abstract]   [Full Text] [Related]  

  • 24. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
    Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
    [No Abstract]   [Full Text] [Related]  

  • 25. Guillain-Barré syndrome after lightning strike.
    Theodorou P; Limmroth V; Perbix W; Gerbershagen M; Knam F; Spilker G
    Burns; 2008 Aug; 34(5):722-6. PubMed ID: 17826913
    [No Abstract]   [Full Text] [Related]  

  • 26. [Facial diplejia: a regional variant of Guillain-Barré syndrome].
    Piñol Ripoll G; Larrodé Pellicer P; de la Puerta González-Miró I; Tejero Juste C; Iñiguez Martínez C; Santos Lasaosa S; Mostacero Miguel E
    An Med Interna; 2007 Jan; 24(1):24-6. PubMed ID: 17373865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome.
    Steinberger B; Coleman TA
    Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    DiMario FJ
    Pediatrics; 2005 Jul; 116(1):226-8. PubMed ID: 15995056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Jun; 12(523):1204-5. PubMed ID: 27487629
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis A virus infection.
    Thapa R; Biswas B; Mallick D; Mukherjee S
    J Child Neurol; 2009 Jul; 24(7):865-7. PubMed ID: 19295182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome.
    Nakajima M
    Eur Neurol; 2005; 54(1):58-60. PubMed ID: 16118497
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous immunoglobulin-associated vena cava thrombosis.
    Marie I; Hervé F; Kerleau JM; Maurey G; Levesque H
    Thromb Haemost; 2006 Dec; 96(6):849-51. PubMed ID: 17139383
    [No Abstract]   [Full Text] [Related]  

  • 33. A 3 1/2-year-old child with bilateral lower extremity pain of 3 weeks duration.
    Sarnaik A; Sethuraman U; Jones E
    Clin Pediatr (Phila); 2009 May; 48(4):440-3. PubMed ID: 18832536
    [No Abstract]   [Full Text] [Related]  

  • 34. A toddler with stridor and leg weakness.
    Godiwala N; Steele RW
    Clin Pediatr (Phila); 2010 Aug; 49(8):809-11. PubMed ID: 20651258
    [No Abstract]   [Full Text] [Related]  

  • 35. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
    Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
    Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posterior reversible encephalopathy syndrome resulting from Guillain-Barré-like syndrome secondary to West Nile virus infection.
    Abraham A; Ziv S; Drory VE
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):113-7. PubMed ID: 21321488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroids in the Guillain-Barré syndrome: is there a therapeutic window?
    Van Koningsveld R; Van Doorn PA
    Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous immunoglobulin induced meningoencephalitis.
    Nooraine J; Iyer RB; Raghavendra S
    Neurol India; 2014; 62(1):98-9. PubMed ID: 24608480
    [No Abstract]   [Full Text] [Related]  

  • 40. Guillain-Barré syndrome with optic neuritis and cytomegalovirus infection.
    Igarashi O; Fujioka T; Kishi M; Normoto N; Iwasaki Y; Kurihara T
    J Peripher Nerv Syst; 2005 Sep; 10(3):340-1. PubMed ID: 16221294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.